Navigation Links
Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
Date:1/11/2008

ite until the next quarterly financial results call.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company currently has two Phase III product candidates in development, Acetavance(TM) (intravenous acetaminophen) for the treatment of acute pain and fever, and Omigard(TM) (omiganan pentahydrochloride 1% topical gel) for the prevention of catheter- related infections. For more information about Cadence's pipeline, visit http://www.cadencepharm.com.

Forward-Looking Statements

Cadence cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements. These include statements regarding: the company's interpretation of the results of recently-completed clinical trials of Acetavance(TM); expectations for completing planned and ongoing clinical trials for both Acetavance and Omigard, and whether such additional clinical trials will be sufficient to support planned New Drug Approval (NDA) applications; the potential for filing, timing and indications for use that may be included in NDAs planned for Acetavance and Omigard; the likelihood that Cadence's clinical trials of Acetavance will be consistent with clinical trials of this product candidate conducted by Cadence's licensor or others; and Cadence's commitment to complete planned development activities for its product candidates. The inclusion of forward-looking statements should not be regarded as a representation by Cadence that any of its plans will be achieved.

Actual results may differ materially from those set forth in this press release due to the risks and uncertainties inherent in Cadence's business, including, without limitation: the outcome of final analyses of data from rec
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
2. American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
3. NPS Pharmaceuticals to Present at the JPMorgan 26th Annual Healthcare Conference on January 9, 2008
4. ISTA Pharmaceuticals Submits New Drug Application for Xibrom(TM) QD (once-daily)
5. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
6. Idenix Pharmaceuticals to Present at the JP Morgan 26th Annual Healthcare Conference
7. Cogentus Pharmaceuticals Completes $62.5 Million Private Financing
8. Cumberland Pharmaceuticals Announces Appointments
9. Pacira Pharmaceuticals Names David M. Stack CEO and President
10. Panacea Pharmaceuticals Initiates GMP Manufacturing of Prostate Cancer Diagnostic Test Kits
11. Sunesis Pharmaceuticals SNS-595 Shows Clinical Activity in Patients With Relapsed or Refractory Acute Leukemias; Data Presented in Oral Session at 49th Annual Meeting of the American Society of Hematology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...panic health advocates committed to achieving mean...N, Nov. 7 "Tonight the ...rd the voice of America,s families by passing the ...nate must deliver, without delay, on the promise o... Delgado, President and CEO of the National Allian...
(Date:11/8/2009)...ealth Care Reform Bill ,, Critical legislatio...all Americans ,, CHICAGO, Nov. 7 /PRNewswire-U...presentatives passed by a vote of 220-215, critica...then Medicare for seniors and end discrimination b...icans out of affordable health coverage. ,, T...
(Date:11/7/2009)...e-USNewswire/ -- Speaker Nancy Pelosi spoke on th...ffordable Health Care for America Act. The House ... are the Speaker,s remarks. ,, "Madam Speaker,...our nation and for American families. For nearly ...ilosophy -- as far back as Teddy Roosevelt -- have...
(Date:11/7/2009)...wswire/ -- Members of the AMA are trying a last-mi...escinding the AMA,s support of HR 3962. ,, "We...le to their PATIENTS, not the leadership of the AM...e Association of American Physicians and Surgeons,...cal groups. ,, "If the AMA leadership ignores ...
(Date:11/7/2009)...or Life Action endorses a key vote today on the Ho...lkemper-Lipinski-Smith Amendment, an Amendment tha...in health care reform. ,, Americans United for Lif...aid, "Americans United for Life Action strongly su...r-Lipinski-Smith Amendment to prohibit abortion ma...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AARP Illinois Key Vote News Alert 2Health News:AARP Illinois Key Vote News Alert 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2
...LC, today announced the,U.S. Food and Drug Adminis...late(TM) devices for use in intervertebral fusion ...solid bone grafts and morselized,bone, without the...erPlate is designed to,facilitate rapid fusion and...
...e, REDMOND, Wash., Sept. 21 EndoGastric Solution...ming Transoral Incisionless,Fundoplication (TIF(TM...sease has received FDA clearance. Patients have al... anesthesia,transoral, incisionless, without any e...
... A new study by researchers at the University of S...od for you. , Researchers found that a storyline...with teen obesity, hypertension and healthy eating...alth Communication and now available online, offer...
...tent symptoms can give warning, experts say , SATU... the "silent killer," may not always be so silent,...ar pelvic exams and pay attention to possible symp...he disease. , September is Ovarian Cancer Awarenes...
...orked hard to get into,summer shape, but now a sea...games may have taken a toll on our waistlines. Now...ck into the one thing that will never lie to,us. ...aphics and,photos for free and unrestricted use at...
...ng is a,statement by Robert Greenstein, executive ...ties, on the new congressional SCHIP agreement:, ... several million,low-income uninsured children, a ...ured, not middle-income children with,private cove...
Other Medicine News:Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 2Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 3Health News:The First Incisionless Transoral Fundoplication for Treatment of Gastroesophageal Reflux is Performed in the U.S. at Ohio State University and Oregon Health & Science University Medical Centers 4Health News:ER episode impacts viewers' health knowledge and behavior 2Health News:Pelvic Exams Can Help Spot Ovarian Cancer 2Health News:Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement 2
(Date:11/6/2009)... MURRYSVILLE, Pa., Nov. 6 Philips ...r Disease Control and Prevention (CDC) to raise aw...chronic sleep insufficiency. The CDC,s release of ...y-state differences in sleeplessness is a mileston.... ,, As a long-time educator, industry leader ...
(Date:11/6/2009)... NEW YORK, Nov. 6 Keryx ...d a conference call on Tuesday, November 10, 2009 ... financial results and business outlook for the re...icer of the Company, will host the call. Keryx wi...in a press release to be issued prior to the call....
(Date:11/6/2009)... ATLANTA, Nov. 6 GeoVax...or "the Company"), an Atlanta-based, biopharmaceut...s caused by HIV-1 (Human Immunodeficiency Virus) a...ird quarter 2009 financial results and provided an...President and Chief Executive Officer commented, "...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Discovery May Pave Way to Better Diabetes Care 56967 1Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference 14004 1Amgen to Present at the Morgan Stanley Global Healthcare Unplugged Conference 14004 2Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 1Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 2Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 3Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 4Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4975 5
...bled Time to Progression and Overall Response Rate...bine + Placebo in Patients with 2nd or 3rd Line Me... Biopharmaceuticals, Inc. (Nasdaq: KERX ) today ...1 (perifosine), the Company,s Akt-inhibitor for ca...ent for advanced colon cancer. Abstract #4081, en...
...SCO Meeting , , INDIANAPOLIS, May 30 Semafore Ph...discovery and development company, today presented...r targeted pan-PI3K/mTORC1/2 inhibitor, SF1126, at...SCO) Annual Meeting, being held in Orlando, Florid...a University Simon Cancer Center in Indianapolis,...
Other Medicine Technology:Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 2Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 3Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 4Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 5Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer 6Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 2Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients 3
... peels are often thought of as very aggressive and...l™ TCA peels are very different from the sta...h many ingredients including lactic acid, ascorbic...c and azelaic acids to produce dramatic results wi...
...ating rapid exfoliator. Lactic Acid is is recommen... agents in skin care products, as well as those th...nd want to improve results. ,Lactic Acid is a natu...h the chemical free style of Peel RX Medi Peel pro...
Specialist's Skin Peel Kit
Glycolic Peels (Medical)
Medicine Products: